Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SEC queries orthopedic device makers

This article was originally published in The Gray Sheet

Executive Summary

Stryker, Zimmer, Biomet, Smith & Nephew and Medtronic confirm the Securities and Exchange Commission is investigating possible violations of the Foreign Corrupt Practices Act in connection with sales to certain countries overseas. The Act prohibits bribery of foreign officials by American companies. Stryker, Zimmer, Biomet and S&N (along with Johnson & Johnson/DePuy) recently settled Department of Justice charges related to allegations of kickbacks to surgeons ("1The Gray Sheet" Oct. 1, 2007, p. 3). J&J/DePuy says it has not received a letter from SEC, however. In February, the firm voluntarily disclosed to SEC and DoJ potential violations of the Foreign Corrupt Practices Act, leading to the resignation of Michael Dormer, worldwide chairman of the firm's device and diagnostics unit ("2The Gray Sheet" Feb. 19, 2007, p. 16)

You may also be interested in...



Foreign Corrupt Practices Act: Device Industry Under Scrutiny

Federal prosecutors have begun targeting medical device companies in Foreign Corrupt Practices Act investigations

Ortho Industry Reaches $311 Mil. Settlement With DoJ On Kickback Charges

Four major hip and knee implant manufacturers will pay the government a total of $311 million to settle anti-kickback claims resulting from a two-year Department of Justice and HHS investigation into the companies' financial relationships with surgeons, the New Jersey U.S. Attorney's office announced Sept. 27

J&J Medical Device Chief Steps Down After Improper Payments Are Disclosed

Worldwide chairman of Johnson & Johnson's medical devices and diagnostics business Michael Dormer abruptly retired Feb. 12 following J&J's disclosure that foreign subsidiaries may have made improper payments in the course of marketing activities

Related Content

Topics

UsernamePublicRestriction

Register

MT025372

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel